Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | LIM domain kinase 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | protein kinase | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Echinococcus multilocularis | dual specificity testis specific protein kinase | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Schistosoma mansoni | protein kinase | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Schistosoma japonicum | ko:K05743 LIM domain kinase 1, putative | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Echinococcus granulosus | dual specificity testis-specific protein kinase | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1598 | 0.1598 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0128 | 0.4533 | 0.4533 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0101 | 0.0101 |
Schistosoma mansoni | protein phosphatase 1 inhibitor potentiated by protein kinase C | 0.0034 | 0.1017 | 0.1017 |
Mycobacterium ulcerans | glutaminase | 0.0274 | 1 | 1 |
Schistosoma mansoni | DNA ligase IV | 0.001 | 0.0101 | 0.0101 |
Echinococcus multilocularis | replication factor c subunit 1 | 0.001 | 0.0101 | 0.019 |
Echinococcus multilocularis | PKC activated phosphatase 1 inhibitor | 0.0034 | 0.1017 | 0.1907 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0101 | 0.0101 |
Loa Loa (eye worm) | TAR-binding protein | 0.0128 | 0.4533 | 0.4533 |
Schistosoma mansoni | protein kinase | 0.015 | 0.5331 | 0.5331 |
Echinococcus granulosus | GPCR family 2 | 0.0016 | 0.0317 | 0.0595 |
Treponema pallidum | DNA ligase (lig) | 0.001 | 0.0101 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.4533 | 0.4533 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0016 | 0.0317 | 0.0317 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.4533 | 0.4533 |
Brugia malayi | hypothetical protein | 0.0034 | 0.1017 | 0.1017 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.1598 | 0.1598 |
Onchocerca volvulus | 0.0034 | 0.1017 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0101 | 0.0101 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0128 | 0.4533 | 0.4533 |
Giardia lamblia | Replication factor C, subunit 1 | 0.001 | 0.0101 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.001 | 0.0101 | 0.5 |
Brugia malayi | Pax transcription activation domain interacting protein | 0.001 | 0.0101 | 0.0101 |
Plasmodium falciparum | replication factor C subunit 1, putative | 0.001 | 0.0101 | 0.5 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.0317 | 0.0595 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0016 | 0.0317 | 0.0317 |
Brugia malayi | RNA binding protein | 0.0128 | 0.4533 | 0.4533 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.4533 | 0.4533 |
Schistosoma mansoni | protein kinase | 0.015 | 0.5331 | 0.5331 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.0317 | 0.0595 |
Echinococcus multilocularis | GPCR, family 2 | 0.0016 | 0.0317 | 0.0595 |
Echinococcus multilocularis | nibrin | 0.001 | 0.0101 | 0.019 |
Schistosoma mansoni | topbp1 | 0.001 | 0.0101 | 0.0101 |
Schistosoma mansoni | glutaminase | 0.0274 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0101 | 0.0101 |
Echinococcus multilocularis | dual specificity testis specific protein kinase | 0.015 | 0.5331 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0274 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.1005 | 0.1005 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.4533 | 0.4533 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0101 | 0.0101 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.1005 | 0.1005 |
Trypanosoma cruzi | FHA domain containing protein, putative | 0.001 | 0.0101 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0101 | 0.0101 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.1598 | 0.1598 |
Echinococcus multilocularis | tar DNA binding protein | 0.0128 | 0.4533 | 0.8503 |
Entamoeba histolytica | Activator 1 140 kDa subunit, putative | 0.001 | 0.0101 | 0.5 |
Trypanosoma cruzi | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.001 | 0.0101 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.001 | 0.0101 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0016 | 0.0317 | 0.0317 |
Brugia malayi | topoisomerase | 0.001 | 0.0101 | 0.0101 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0317 | 0.0317 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0317 | 0.0317 |
Entamoeba histolytica | hypothetical protein | 0.001 | 0.0101 | 0.5 |
Trichomonas vaginalis | glutaminase, putative | 0.0274 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1005 | 0.1005 |
Chlamydia trachomatis | DNA ligase | 0.001 | 0.0101 | 0.5 |
Brugia malayi | hypothetical protein | 0.001 | 0.0101 | 0.0101 |
Brugia malayi | TAR-binding protein | 0.0128 | 0.4533 | 0.4533 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0317 | 0.0317 |
Schistosoma mansoni | chromosome transmission fidelity factor | 0.001 | 0.0101 | 0.0101 |
Echinococcus granulosus | replication factor c subunit 1 | 0.001 | 0.0101 | 0.019 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0317 | 0.0317 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.4533 | 0.4533 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1017 | 0.1017 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.0317 | 0.0595 |
Echinococcus granulosus | tar DNA binding protein | 0.0128 | 0.4533 | 0.8503 |
Toxoplasma gondii | ATPase, AAA family protein | 0.001 | 0.0101 | 0.5 |
Mycobacterium leprae | PROBABLE DNA LIGASE [NAD DEPENDENT] LIGA (POLYDEOXYRIBONUCLEOTIDE SYNTHASE [NAD+]) | 0.001 | 0.0101 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0317 | 0.0317 |
Onchocerca volvulus | 0.001 | 0.0101 | 0.0998 | |
Wolbachia endosymbiont of Brugia malayi | NAD-dependent DNA ligase, Lig | 0.001 | 0.0101 | 0.5 |
Echinococcus granulosus | nibrin | 0.001 | 0.0101 | 0.019 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.0317 | 0.0595 |
Toxoplasma gondii | poly(ADP-ribose) polymerase catalytic domain-containing protein | 0.001 | 0.0101 | 0.5 |
Plasmodium vivax | replication factor C subunit 1, putative | 0.001 | 0.0101 | 0.5 |
Echinococcus granulosus | PKC activated phosphatase 1 inhibitor | 0.0034 | 0.1017 | 0.1907 |
Brugia malayi | DKFZp564C0469 protein | 0.001 | 0.0101 | 0.0101 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.1598 | 0.1598 |
Brugia malayi | hypothetical protein | 0.001 | 0.0101 | 0.0101 |
Trypanosoma brucei | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.001 | 0.0101 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0128 | 0.4533 | 0.4533 |
Loa Loa (eye worm) | glutaminase | 0.0274 | 1 | 1 |
Schistosoma mansoni | topbp1 | 0.001 | 0.0101 | 0.0101 |
Brugia malayi | ATP dependent DNA ligase C terminal region family protein | 0.001 | 0.0101 | 0.0101 |
Echinococcus granulosus | dual specificity testis-specific protein kinase | 0.015 | 0.5331 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 220 nM | Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP | ChEMBL. | 25589936 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.